![Collette Coll](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Collette Coll currently works at Celleron Therapeutics Ltd., as Operations Director, Argonaut Therapeutics Ltd., as Operations Director, and Ingenox Therapeutics Ltd., as Co-Operations Director.
Actieve functies van Collette Coll
| Bedrijven | Functie | Begin |
|---|---|---|
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Operationeel Directeur | - |
Ingenox Therapeutics Ltd.
 Ingenox Therapeutics Ltd. BiotechnologyHealth Technology Develops drugs and precision cancer vaccines for advanced & treatment-resistant cancers | Operationeel Directeur | - |
Argonaut Therapeutics Ltd.
 Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Develops epigenetically-acting drugs which target abnormal arginine methylation in cancer | Operationeel Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
15
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Celleron Therapeutics Ltd.
Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Health Technology |
Argonaut Therapeutics Ltd.
Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Develops epigenetically-acting drugs which target abnormal arginine methylation in cancer | Health Technology |
Ingenox Therapeutics Ltd.
Ingenox Therapeutics Ltd. BiotechnologyHealth Technology Develops drugs and precision cancer vaccines for advanced & treatment-resistant cancers | Health Technology |
